abstract |
Esters of arginine (L- and/or D- enantiomers) with D-galactose useful as prodrugs are described, possessing a high capacity for penetrating cell membranes and the blood-brain barrier. The esters of the invention, once absorbed, gradually release arginine and ensure prolonged and high levels of the drug, generating a substantial and extended therapeutic response over time. |